188 related articles for article (PubMed ID: 15094035)
1. On the road to immortality: hTERT upregulation in cancer cells.
Janknecht R
FEBS Lett; 2004 Apr; 564(1-2):9-13. PubMed ID: 15094035
[TBL] [Abstract][Full Text] [Related]
2. Opposing regulatory roles of E2F in human telomerase reverse transcriptase (hTERT) gene expression in human tumor and normal somatic cells.
Won J; Yim J; Kim TK
FASEB J; 2002 Dec; 16(14):1943-5. PubMed ID: 12368233
[TBL] [Abstract][Full Text] [Related]
3. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
[TBL] [Abstract][Full Text] [Related]
4. Telomerase reverse transcriptase promotes epithelial-mesenchymal transition and stem cell-like traits in cancer cells.
Liu Z; Li Q; Li K; Chen L; Li W; Hou M; Liu T; Yang J; Lindvall C; Björkholm M; Jia J; Xu D
Oncogene; 2013 Sep; 32(36):4203-13. PubMed ID: 23045275
[TBL] [Abstract][Full Text] [Related]
5. Differential transcriptional regulation of human telomerase in a cellular model representing important genetic alterations in esophageal squamous carcinogenesis.
Quante M; Heeg S; von Werder A; Goessel G; Fulda C; Doebele M; Nakagawa H; Beijersbergen R; Blum HE; Opitz OG
Carcinogenesis; 2005 Nov; 26(11):1879-89. PubMed ID: 15958520
[TBL] [Abstract][Full Text] [Related]
6. Lack of telomerase gene expression in alternative lengthening of telomere cells is associated with chromatin remodeling of the hTR and hTERT gene promoters.
Atkinson SP; Hoare SF; Glasspool RM; Keith WN
Cancer Res; 2005 Sep; 65(17):7585-90. PubMed ID: 16140922
[TBL] [Abstract][Full Text] [Related]
7. Upstream stimulatory factor (USF) as a transcriptional suppressor of human telomerase reverse transcriptase (hTERT) in oral cancer cells.
Chang JT; Yang HT; Wang TC; Cheng AJ
Mol Carcinog; 2005 Nov; 44(3):183-92. PubMed ID: 16010690
[TBL] [Abstract][Full Text] [Related]
8. Regulation of the human telomerase reverse transcriptase gene.
Ducrest AL; Szutorisz H; Lingner J; Nabholz M
Oncogene; 2002 Jan; 21(4):541-52. PubMed ID: 11850779
[TBL] [Abstract][Full Text] [Related]
9. Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells.
Takakura M; Kyo S; Kanaya T; Hirano H; Takeda J; Yutsudo M; Inoue M
Cancer Res; 1999 Feb; 59(3):551-7. PubMed ID: 9973199
[TBL] [Abstract][Full Text] [Related]
10. Differential gene expressions during immortalization of normal human fibroblasts and endothelial cells transfected with human telomerase reverse transcriptase gene.
Kumazaki T; Hiyama K; Takahashi T; Omatsu H; Tanimoto K; Noguchi T; Hiyama E; Mitsui Y; Nishiyama M
Int J Oncol; 2004 Jun; 24(6):1435-42. PubMed ID: 15138585
[TBL] [Abstract][Full Text] [Related]
11. Suppressor of Ty homolog-5, a novel tumor-specific human telomerase reverse transcriptase promoter-binding protein and activator in colon cancer cells.
Chen R; Zhu J; Dong Y; He C; Hu X
Oncotarget; 2015 Oct; 6(32):32841-55. PubMed ID: 26418880
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation of the TERT promoter and its impact on human cancer.
Lee DD; Komosa M; Nunes NM; Tabori U
Curr Opin Genet Dev; 2020 Feb; 60():17-24. PubMed ID: 32114294
[TBL] [Abstract][Full Text] [Related]
13. Role of menin in the regulation of telomerase activity in normal and cancer cells.
Hashimoto M; Kyo S; Hua X; Tahara H; Nakajima M; Takakura M; Sakaguchi J; Maida Y; Nakamura M; Ikoma T; Mizumoto Y; Inoue M
Int J Oncol; 2008 Aug; 33(2):333-40. PubMed ID: 18636154
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms for telomerase gene control in aging cells and tumorigenesis.
Tollefsbol TO; Andrews LG
Med Hypotheses; 2001 Jun; 56(6):630-7. PubMed ID: 11399111
[TBL] [Abstract][Full Text] [Related]
15. Cell cycle-specific changes in hTERT promoter activity in normal and cancerous cells in adenoviral gene therapy: a promising implication of telomerase-dependent targeted cancer gene therapy.
Murofushi Y; Nagano S; Kamizono J; Takahashi T; Fujiwara H; Komiya S; Matsuishi T; Kosai K
Int J Oncol; 2006 Sep; 29(3):681-8. PubMed ID: 16865285
[TBL] [Abstract][Full Text] [Related]
16. The Bmi-1 oncogene induces telomerase activity and immortalizes human mammary epithelial cells.
Dimri GP; Martinez JL; Jacobs JJ; Keblusek P; Itahana K; Van Lohuizen M; Campisi J; Wazer DE; Band V
Cancer Res; 2002 Aug; 62(16):4736-45. PubMed ID: 12183433
[TBL] [Abstract][Full Text] [Related]
17. [Relationship between human telomerase reverse transcriptase transcriptional level and telomerase activity in three ovarian cancer cell lines].
Song Y; Kong BH; Liu PS; Ma DX; Jiang S
Ai Zheng; 2003 May; 22(5):486-91. PubMed ID: 12753708
[TBL] [Abstract][Full Text] [Related]
18. Repression of human telomerase reverse transcriptase using artificial zinc finger transcription factors.
Sohn JH; Yeh BI; Choi JW; Yoon J; Namkung J; Park KK; Kim HW
Mol Cancer Res; 2010 Feb; 8(2):246-53. PubMed ID: 20145034
[TBL] [Abstract][Full Text] [Related]
19. Telomere shortening and telomerase reverse transcriptase expression in preinvasive bronchial lesions.
Lantuejoul S; Soria JC; Morat L; Lorimier P; Moro-Sibilot D; Sabatier L; Brambilla C; Brambilla E
Clin Cancer Res; 2005 Mar; 11(5):2074-82. PubMed ID: 15756034
[TBL] [Abstract][Full Text] [Related]
20. Regulation of telomerase reverse transcriptase gene activity by upstream stimulatory factor.
Goueli BS; Janknecht R
Oncogene; 2003 Sep; 22(39):8042-7. PubMed ID: 12970752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
